Persisting with Purpose: Using Acceptance and Commitment Therapy to Target Comorbid Opioid Use Disorder and Chronic Pain in a Racially and Economically Marginalized Population.

Yash Bhambhani, Laurie Gallo, Emily O McNamara, Angela Stotts, Vilma Gabbay
Author Information
  1. Yash Bhambhani: Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, 10467, USA.
  2. Laurie Gallo: Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, 10467, USA.
  3. Emily O McNamara: Madison Park Psychological Services.
  4. Angela Stotts: Department of Psychiatry and Behavioral Sciences, University of Texas Medical School at Houston.
  5. Vilma Gabbay: Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY.

Abstract

Opioid use disorder (OUD) and chronic pain (CP) are commonly comorbid health conditions that cause significant disability, distress, and mortality. Treatment for these conditions is impacted by drop out and presence of other psychiatric conditions. Acceptance and Commitment Therapy is an effective intervention to treat chronic pain and substance use disorders, however this intervention has not been systematically evaluated for treatment of comorbid OUD and CP, especially in a racially and economically marginalized population. In this paper we describe development of such an ACT manual, using an intervention mapping approach. While the manual pays close attention to opioid use and chronic pain, it includes transdiagnostic principles that target overall psychological well-being including a deep emphasis on expanding valued living. We incorporated trauma informed care, cultural humility, and harm reduction principles in the development of nine ACT skills that are easy to understand and scalable. The treatment manual centers economically and racially marginalized patients who are traditionally underrepresented in psychological research. This manual is currently being evaluated in clinical trial NCT05039554 with funding from the NIH HEAL project #RM1DA055437. The treatment manual and handouts are freely available for use and included.

References

  1. Internet Interv. 2022 Nov 11;30:100585 [PMID: 36426200]
  2. Prev Med Rep. 2022 Aug 19;29:101952 [PMID: 36161119]
  3. Int J Psychol. 2014 Apr;49(2):98-107 [PMID: 24811880]
  4. J Dual Diagn. 2020 Apr-Jun;16(2):191-207 [PMID: 32089124]
  5. Behav Res Ther. 2023 Dec;171:104440 [PMID: 37992482]
  6. BMJ Open. 2019 May 14;9(5):e030259 [PMID: 31092670]
  7. Psychiatr Serv. 2005 Aug;56(8):913-26 [PMID: 16088007]
  8. Addiction. 2007 May;102(5):752-60 [PMID: 17506152]
  9. Behav Res Ther. 2011 Apr;49(4):267-74 [PMID: 21377652]
  10. Curr Opin Psychol. 2015 Apr 1;2:75-81 [PMID: 26693170]
  11. Behav Ther. 2021 Mar;52(2):492-507 [PMID: 33622516]
  12. JAMA. 2003 May 14;289(18):2370-8 [PMID: 12746360]
  13. Pain Manag Nurs. 2014 Sep;15(3):641-51 [PMID: 24144571]
  14. Clin Psychol Psychother. 2021 Jan;28(1):150-158 [PMID: 32789901]
  15. Subst Use Addctn J. 2025 Jan;46(1):166-174 [PMID: 39171416]
  16. PLoS One. 2022 Mar 18;17(3):e0265480 [PMID: 35303025]
  17. J Pain. 2013 Nov;14(11):1398-406 [PMID: 24035351]
  18. Child Abuse Negl. 2013 Nov;37(11):917-25 [PMID: 23978575]
  19. Pain. 2011 Mar;152(3):533-542 [PMID: 21251756]
  20. N Engl J Med. 2023 May 11;388(19):1779-1789 [PMID: 37163624]
  21. Pain Med. 2024 Feb 1;25(2):131-138 [PMID: 37738606]
  22. Headache. 2021 Jun;61(6):895-905 [PMID: 34115399]
  23. Front Psychol. 2021 Oct 28;12:758356 [PMID: 34777161]
  24. Cogn Behav Ther. 2008;37(3):169-82 [PMID: 18608312]
  25. Drug Alcohol Depend. 2012 Oct 1;125(3):215-22 [PMID: 22425411]
  26. Int J Environ Res Public Health. 2022 Dec 07;19(24): [PMID: 36554315]
  27. Pain. 2005 Jan;113(1-2):9-19 [PMID: 15621359]
  28. Eur J Pain. 2007 Oct;11(7):779-87 [PMID: 17303452]
  29. Pain. 2015 Apr;156(4):569-576 [PMID: 25785523]
  30. MMWR Morb Mortal Wkly Rep. 2024 Jun 27;73(25):567-574 [PMID: 38935567]
  31. J Contemp Psychother. 2016;46:139-148 [PMID: 27397934]
  32. Am Psychol. 2020 Dec;75(9):1300-1311 [PMID: 33382299]
  33. J Subst Abuse Treat. 2017 Jun;77:26-30 [PMID: 28476267]
  34. J Subst Abuse Treat. 2019 Apr;99:104-116 [PMID: 30797382]
  35. Patient Educ Couns. 2017 Feb;100(2):372-376 [PMID: 27665499]
  36. Pain Manag Nurs. 2014 Jun;15(2):499-505 [PMID: 24882027]
  37. J Clin Psychol. 2021 Feb;77(2):429-440 [PMID: 33506991]
  38. Internet Interv. 2023 Feb 27;32:100611 [PMID: 36910302]
  39. Eur J Pain. 2022 Jan;26(1):167-180 [PMID: 34375444]
  40. Harv Rev Psychiatry. 2015 Mar-Apr;23(2):76-89 [PMID: 25747921]
  41. Pain. 2010 Jan;148(1):141-147 [PMID: 19945795]
  42. Psychotherapy (Chic). 2018 Mar;55(1):63-72 [PMID: 29565623]
  43. Front Psychol. 2016 Aug 31;7:1326 [PMID: 27630601]
  44. Br J Gen Pract. 2015 Jun;65(635):e387-400 [PMID: 26009534]
  45. J Clin Psychol. 2014 Jul;70(7):644-57 [PMID: 24449031]
  46. Am J Drug Alcohol Abuse. 2024 Jul 3;50(4):455-461 [PMID: 39018662]
  47. World Psychiatry. 2016 Oct;15(3):295-296 [PMID: 27717271]
  48. Ann Behav Med. 2017 Apr;51(2):199-213 [PMID: 27658913]
  49. J Pain Res. 2018 Oct 02;11:2145-2159 [PMID: 30323649]
  50. J Pain. 2018 Oct;19(10):1211-1221 [PMID: 29777950]
  51. Behav Res Ther. 2006 Jan;44(1):1-25 [PMID: 16300724]
  52. Ann Intern Med. 2007 Jan 16;146(2):116-27 [PMID: 17227935]
  53. J Clin Med Res. 2020 Oct;12(10):629-633 [PMID: 33029268]
  54. J Couns Psychol. 2013 Jul;60(3):353-366 [PMID: 23647387]
  55. Psychiatr Clin North Am. 2017 Dec;40(4):751-770 [PMID: 29080598]
  56. Drug Alcohol Rev. 2008 Jan;27(1):83-90 [PMID: 18034385]
  57. Lancet. 2013 Nov 9;382(9904):1564-74 [PMID: 23993281]
  58. Health Educ Behav. 1998 Oct;25(5):545-63 [PMID: 9768376]
  59. Br J Health Psychol. 2012 May;17(2):314-26 [PMID: 22107355]
  60. Neurotherapeutics. 2017 Jul;14(3):546-553 [PMID: 28271287]
  61. J Pain. 2020 Jul - Aug;21(7-8):798-807 [PMID: 31760109]
  62. J Transcult Nurs. 2016 May;27(3):210-7 [PMID: 26122618]
  63. Am J Public Health. 2022 Feb;112(2):284-295 [PMID: 35080954]
  64. Pediatrics. 2003 Mar;111(3):564-72 [PMID: 12612237]
  65. J Racial Ethn Health Disparities. 2023 Aug;10(4):2039-2053 [PMID: 36068482]
  66. Addict Res Theory. 2008;16(2):149-165 [PMID: 27746709]
  67. CMAJ. 2016 Dec 6;188(17-18):E474-E483 [PMID: 27503870]
  68. Behav Ther. 2023 Nov;54(6):1036-1063 [PMID: 37863584]
  69. Glob Ment Health (Camb). 2018 Aug 13;5:e27 [PMID: 30128163]
  70. J Clin Psychol. 2016 Apr;72(4):311-28 [PMID: 27002222]
  71. Behav Res Ther. 2005 Oct;43(10):1335-46 [PMID: 16086984]
  72. Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):99-104 [PMID: 24211157]
  73. J Clin Psychol. 2010 Feb;66(2):201-14 [PMID: 20049923]
  74. PLoS One. 2019 Aug 20;14(8):e0221437 [PMID: 31430355]
  75. J Pain. 2021 Feb;22(2):143-160 [PMID: 32682815]
  76. Nat Sci Sleep. 2023 Jul 05;15:523-531 [PMID: 37431325]
  77. J Addict Dis. 2017 Jul-Sep;36(3):151-157 [PMID: 28358236]
  78. J Consult Clin Psychol. 2008 Jun;76(3):397-407 [PMID: 18540733]
  79. J Addict Med. 2007 Jun;1(2):104-10 [PMID: 21768942]
  80. Psychiatry Res Neuroimaging. 2016 Apr 30;250:12-4 [PMID: 27107155]
  81. Pain. 2016 Jan;157(1):65-69 [PMID: 26307855]
  82. Eur J Pain. 2013 Apr;17(4):599-611 [PMID: 23090719]
  83. Harm Reduct J. 2023 Feb 25;20(1):24 [PMID: 36841763]
  84. Addiction. 2022 Mar;117(3):760-771 [PMID: 34890104]
  85. J Psychopharmacol. 2011 Jan;25(1):17-25 [PMID: 20093318]
  86. Health Psychol Res. 2013 Sep 23;1(3):e34 [PMID: 26973919]
  87. Clin J Pain. 2011 Oct;27(8):716-23 [PMID: 21540740]
  88. Qual Life Res. 2010 Nov;19(9):1311-21 [PMID: 20593306]
  89. Psychiatr Clin North Am. 2022 Sep;45(3):529-546 [PMID: 36055737]
  90. Am J Addict. 2010 Sep-Oct;19(5):409-15 [PMID: 20716303]
  91. Psychol Sci. 2020 Jun;31(6):678-701 [PMID: 32437234]
  92. Drug Alcohol Depend. 2015 Oct 1;155:1-7 [PMID: 26298552]

Grants

  1. RM1 DA055437/NIDA NIH HHS

Word Cloud

Created with Highcharts 10.0.0manualusechronicpainconditionsinterventiontreatmentOpioidOUDCPcomorbidAcceptanceCommitmentTherapyevaluatedraciallyeconomicallymarginalizeddevelopmentACTprinciplespsychologicaldisordercommonlyhealthcausesignificantdisabilitydistressmortalityTreatmentimpacteddroppresencepsychiatriceffectivetreatsubstancedisordershoweversystematicallyespeciallypopulationpaperdescribeusingmappingapproachpayscloseattentionopioidincludestransdiagnostictargetoverallwell-beingincludingdeepemphasisexpandingvaluedlivingincorporatedtraumainformedcareculturalhumilityharmreductionnineskillseasyunderstandscalablecenterspatientstraditionallyunderrepresentedresearchcurrentlyclinicaltrialNCT05039554fundingNIHHEALproject#RM1DA055437handoutsfreelyavailableincludedPersistingPurpose:UsingTargetComorbidUseDisorderChronicPainRaciallyEconomicallyMarginalizedPopulation

Similar Articles

Cited By